SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,000 | +100.0% | 6,430 | +94.8% | 0.00% | – |
Q1 2022 | $3,000 | -62.5% | 3,300 | +35.2% | 0.00% | – |
Q4 2021 | $8,000 | +700.0% | 2,440 | +454.5% | 0.00% | – |
Q3 2021 | $1,000 | -66.7% | 440 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 440 | +10.0% | 0.00% | – |
Q1 2021 | $3,000 | +200.0% | 400 | +300.0% | 0.00% | – |
Q4 2020 | $1,000 | -83.3% | 100 | -84.6% | 0.00% | – |
Q3 2020 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | – |
Q2 2020 | $7,000 | +75.0% | 650 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | – | 650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |